- Prof. Yitshak Kreiss, Director General, Sheba Medical Center
- Philippe Gallone, Partner and Head of Healthcare Investment Banking in EMEA, Goldman Sachs
- Prof. Yinon Ben Neriah, The Faculty of Medicine, Hebrew University of Jerusalem, Awarded 2025 the Israel Prize in the Field of Medical Research
In War-Time Innovation, Peace-Time Solutions, Avner Halperin, CEO of Sheba Impact, explores how crisis-driven breakthroughs can be transformed into lasting advancements for the future of medicine. Meanwhile, Rewiring the Brain takes a closer look at the latest breakthroughs in neurotech and neuromodulation, with Barry Greene, CEO of Sage Therapeutics, and Iris Grossman, PhD, Chief Therapeutics Officer at Eleven Therapeutics, leading the conversation.The intersection of artificial intelligence and biotechnology comes into focus in AI Meets Pharma, where Karin Noy, PhD, Senior Director at Pfizer, and Ofran Yanay, PhD, Founder and Chairman of Biolojic Design, discuss building sustainable value for Biotech AI innovation in drug development. As the healthcare landscape evolves, Personalized Medicine raises critical questions about strategic pathways—should the focus be on pharma, payers, or both? Ofer Sharon, MD, CEO of OncoHost, guides this exploration of the future of tailored treatments. Further the relentless pursuit of innovation in oncology takes center stage in Redefining the Fight Against Cancer, where Yaron Daniely, PhD, General Partner at aMoon Fund, delves into new targets and novel therapeutic modalities shaping the next wave of cancer treatment.
- Dror Bin, Chief Executive Officer, Israel Innovation Authority
Bankers and VC Panel: “The Investment Tango: VCs, Bankers, and the Dance of Deal-Making”
Bankers:
- Michael Margolis, Senior Managing Director, Head of Healthcare Investment Banking, Oppenheimer & Co.
- Michael Rice, Founding Partner, LifeSci Advisors
Venture Capital:
- Nick Pachuda, MD General Partner, Neovate Capital Partners
- Mitchell Gold, MD, Venture Partner, Frazier Life Sciences; Alpine Immune Sciences, Ex-CEO
- Jing Bao, MD, PhD., Partner, Shanghai Healthcare Capital (SHC)
Craig Yeshion, MD, Managing Director, Specialty Pharmaceuticals & Medical Devices, Perceptive Advisors
- Boaz Hirshberg, MD, Senior Vice President, Clinical Development Unit Head, Internal Medicine, Regeneron
As immunology and inflammation take center stage in biopharma, (I&I) Immunology and Inflammation Reclaim Top Priorities in BioPharma explores the key drivers and emerging opportunities in this evolving field, led by Iris Grossman, PhD, Chief Therapeutics Officer at Eleven Therapeutics, and Prof. Amnon Peled, MD, of Hadassah Medical Center. At the cutting edge of technology and biology, Frontiers in Bio-Chip and Bio-Devices examines the advancements redefining bio-integrated systems, with Shai Melcer, PhD, Head of Bio-Convergence at the Israel Innovation Authority, guiding the conversation. Meanwhile, breakthroughs in genetics and cellular therapies continue to open new possibilities for rare and complex diseases in Personalized Pathways, where Gili Hart, PhD, CEO of Splisense, and Ayal Hendel, Assoc. Prof. at Bar-Ilan University, discuss the latest advances in precision medicine. The future of eye health takes focus in Illuminating the Path, as Anat Loewenstein, MD, President of the Israeli Ophthalmological Society and Dean of the Faculty of Medicine at Tel Aviv University, joins Barak Azmon, MD, Entrepreneur, and Jonathan Weyne, MD, Vice President of Ophthalmology Therapeutics at Regeneron, to explore innovations and challenges shaping ophthalmology. As research into aging accelerates, Aging Redefined highlights the latest breakthroughs in longevity science and technology, with Varda Shalev, MD, Managing Partner at Team8 Health, leading the discussion on extending and improving human lifespan. Shifting to the future of food, The Next Bite delves into evidence-based, bio-food by design, moderated by Tammy Meiron, PhD, Chief Technology Officer at Fresh Start FoodTech Incubator, showcasing how science and innovation are transforming the way we eat. From personalized medicine to bio-food innovations, these discussions bring together industry pioneers to explore the future of healthcare, technology, and well-being.
- Rony Paz; Dean, Faculty of Biology; Director, Azrieli Institute for Brain and Neural Sciences; Weizmann Institute of Science
- Nick Pachuda, MD., General Partner, Neovate Capital Markets
With continuous advancements shaping the field, Evolving Trends in Orthopedic Innovations explores the latest breakthroughs in musculoskeletal treatments, guided by Yuval Mandelbaum, CEO of Discure Technologies. Addressing the critical need for gender-specific healthcare solutions, Mind the Gap focuses on empowering women’s health through data and innovation, with Inbal Zafir-Lavie, Ph.D., BOD Member at Nevia Bio, and Avital Adler, Ph.D., Entrepreneur and Investor, leading the discussion. The future of biomedical entrepreneurship takes center stage in Defining the Future – BioMed Start-ups Showcase and Competition, where Yael Gruenbaum-Cohen, DMD, Ph.D., Partner & Head of aMoon Alpha, and Adar Makovski-Silverstein, Ph.D., of Arkin Capital, highlight promising ventures redefining healthcare. Navigating the journey from concept to success, Medical Device Company uncovers the strategic pathways that turn visionary ideas into thriving businesses, with Irit Yaniv, MD, Founding Partner and CEO of Almeda Ventures, and Gilad Glick, Venture Investments – MedTech at Johnson & Johnson Development Corp., sharing their insights. Meanwhile, the transformative role of artificial intelligence in healthcare is explored in AI’s Next Leap in HealthTech, where Avi Veidman, CEO of Nucleai, examines how AI-driven solutions are reshaping medical applications and giving rise to transformative opportunities in health care. Bringing together thought leaders and innovators, these discussions explore the evolving landscape of healthcare technology, investment, and clinical advancements.
